OR WAIT null SECS
© 2021 MJH Life Sciences and Pharmaceutical Executive. All rights reserved.
© 2021 MJH Life Sciences™ and Pharmaceutical Executive. All rights reserved.
October 14, 2021
Creating a digital diagnostic that is supplemental and strategic to a company’s therapeutic asset requires due diligence to monetize the digital health innovation, or at least ensure optionality through the product development cycle.
Clay Hausmann describes how Almirall is weeding out uncertainty to sow the seeds of data-driven digital transformation.
October 12, 2021
Unconventional collaborations between biopharma and tech are starting to take off.
While there is broad agreement that the Chief Data Officer plays a critical part in pharma, a definitive description of the role is still evolving.
How the sharing of scientific content with HCPs is shifting in an era of accelerated digitalization.
September 23, 2021
Medical science liaisons (MSL) in the pharma industry were already at their limit pre-COVID. The challenge for MSLs is to identify the most efficient way to upskill their teams and add digital competencies without overloading them.
September 21, 2021
In today‘s environment, medical science liaisons (MSLs) must call on digital solutions to make use of the right data and encourage the right conversations to take place.
September 17, 2021
”Soft skills” are notoriously difficult to teach. For that reason, many trainers are applying state-of-the-art computer simulations to help develop these skills within pharma sales organizations, writes Jeremy Lovelace.
September 15, 2021
How a large, global biopharma company is leveraging a data-linking strategy to power insight-generation tools and techniques—and supporting customers through their journey with dynamic personalization and modular content.
September 14, 2021
Leslie Rotz and Todd Parker outline four major steps in the Medical Affairs digital transformation journey.